Cargando…

Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment

Detalles Bibliográficos
Autores principales:	Rossio, Raffaella, Tettamanti, Mauro, Nobili, Alessandro, Harari, Sergio, Mannucci, Pier Mannuccio, Bandera, Alessandra, Peyvandi, Flora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Ce - Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329608/ https://www.ncbi.nlm.nih.gov/pubmed/34342788 http://dx.doi.org/10.1007/s11739-021-02807-8

Ejemplares similares

Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment
por: Bandera, Alessandra, et al.
Publicado: (2021)

Pharmaceutical patenting in the European Union: reform or riddance
por: Garattini, Livio, et al.
Publicado: (2021)

What changed in the Italian internal medicine and geriatric wards during the lockdown
por: D'Avanzo, Barbara, et al.
Publicado: (2021)

Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes
por: Ardoino, Ilaria, et al.
Publicado: (2023)

Post-COVID condition: dispensation of drugs and diagnostic tests as proxies of healthcare impact
por: Nobili, Alessandro, et al.
Publicado: (2023)

High-dose steroids for the treatment of severe COVID-19: comment
por: Tanaka, Shuichi, et al.
Publicado: (2021)

The Italian NHS in Lombardy and Veneto: near but far
por: Garattini, Livio, et al.
Publicado: (2021)

Genome-Wide Association Studies in Myocardial Infarction and Coronary Artery Disease
por: Mannucci, Pier Mannuccio, et al.
Publicado: (2010)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment
por: Yurttutan, Sadık, et al.
Publicado: (2021)

Comments on “To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case–control analysis, in primary care”
por: Chirumbolo, Salvatore, et al.
Publicado: (2023)

Lung ultrasound presentation of covid-19 patients: phenotypes and correlations—comment
por: Nekludova, Galina, et al.
Publicado: (2021)

Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium
por: Nobili, Alessandro, et al.
Publicado: (2011)

Novel evidence for a greater burden of ambient air pollution on cardiovascular disease
por: Mannucci, Pier Mannuccio, et al.
Publicado: (2019)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment
por: Ponzetto, Antonio, et al.
Publicado: (2020)

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases: Comment
por: Magon, Arianna, et al.
Publicado: (2021)

“Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine”: comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy
por: Hassan, Shermarke, et al.
Publicado: (2022)

Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010)

Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009)

Orthostatic hypotension among elderly patients in Italian internal medicine wards: an observational study—comment
por: Bolek, Hatice, et al.
Publicado: (2020)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
por: Allione, Attilio, et al.
Publicado: (2020)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
por: Roncon, Loris, et al.
Publicado: (2020)

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment
por: Rajput, Dinesh Vijay
Publicado: (2020)

Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2021)

High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?
por: Cameli, Paolo, et al.
Publicado: (2021)

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up: comment
por: Serraino, Cristina, et al.
Publicado: (2022)

Impact of the post‐COVID‐19 condition on health care after the first disease wave in Lombardy
por: Mannucci, Pier M., et al.
Publicado: (2022)

Hospital mortality and failure of non-invasive ventilation in COVID-19: looking inside the predictive scores
por: Piazza, Isabelle, et al.
Publicado: (2022)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment
por: De Cauwer, Harald
Publicado: (2020)

Role of doctors in epidemics: historical perspectives and implications for COVID-19
por: Lippi, Donatella, et al.
Publicado: (2020)

External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019
por: Hassan, Shermarke, et al.
Publicado: (2022)

Corrigendum to ‘External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019’
por: Hassan, Shermarke, et al.
Publicado: (2022)

SARS-CoV-2 vs smallpox: mass vaccinations in the mirror
por: Bianucci, Raffaella, et al.
Publicado: (2021)

Two-years chest-CT follow-up after severe COVID-19 pneumonia
por: Flor, Nicola, et al.
Publicado: (2023)

Pain and Frailty in Hospitalized Older Adults
por: Ardoino, Ilaria, et al.
Publicado: (2020)

SIADH and severe COVID-19 pneumonia in elderly patients: a therapeutic challenge in developing countries
por: Concepción Zavaleta, Marcio Jose, et al.
Publicado: (2021)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

The need for a correct oxygen-ozone autohemotherapy (O(3)-AHT) in patients with mild to moderate COVID-19 pneumonia
por: Chirumbolo, Salvatore, et al.
Publicado: (2021)

High-dose steroids for the treatment of severe COVID-19
por: Piccica, Matteo, et al.
Publicado: (2021)

Procalcitonin for the differential diagnosis of COVID-19 in the emergency department. Prospective monocentric study
por: Nazerian, Peiman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ec12eep0q1bmtb06a923pj265a